OPNT insider filings
OPIANT PHARMACEUTICALS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-03. Screen OPNT transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for OPNT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — OPIANT PHARMACEUTICALS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-03 | 4 | Silver Gabrielle Alison — Director | Disposition to issuer (D): 21,343 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Ruth Matthew R. — Chief Commercial Officer | Disposition to issuer (D): 19,250 @ $20 · Disposition to issuer (D): 10,666 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 50,000 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Daly Richard J — Director | Disposition to issuer (D): 5,800 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | CRYSTAL ROGER — Chief Executive Officer, Director, 10% owner | Disposition to issuer (D): 37,438 @ $20 · Disposition to issuer (D): 37,901 @ $20 · Disposition to issuer (D): 5,100 @ $20 · Grant/award (A): 6,667 @ $0 · Disposition to issuer (D): 6,667 @ $20 · Disposition to issuer (D): 25,000 (derivative) @ $0 · +6 more | EDGAR |
| 2023-03-03 | 4 | Ellison Mark Jason Heath — Chief Development Officer | Disposition to issuer (D): 7,015 @ $20 · Disposition to issuer (D): 11,736 @ $20 · Disposition to issuer (D): 9,680 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 7,200 (derivative) @ $0 · +2 more | EDGAR |
| 2023-03-03 | 4 | Sinclair Michael — Director, 10% owner | Disposition to issuer (D): 27,450 @ $20 · Disposition to issuer (D): 22,720 @ $20 · Disposition to issuer (D): 40,000 @ $20 · Disposition to issuer (D): 100,000 (derivative) @ $0 · Disposition to issuer (D): 250,000 (derivative) @ $0 · Disposition to issuer (D): 75,000 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | MacDougall Ann L. — Director | Disposition to issuer (D): 26,179 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Lorianne Masuoka K. — Director | Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Gorman Brian | Disposition to issuer (D): 14,540 @ $20 · Disposition to issuer (D): 17,450 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 36,500 (derivative) @ $0 · Disposition to issuer (D): 10,750 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Thomas Thomas T. — Director | Disposition to issuer (D): 10,375 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | O'Toole David D — Chief Financial Officer | Disposition to issuer (D): 22,512 @ $20 · Disposition to issuer (D): 11,736 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 33,000 (derivative) @ $0 · Disposition to issuer (D): 8,250 (derivative) @ $0 · +1 more | EDGAR |
| 2023-03-03 | 4 | Collard Craig A — Director | Disposition to issuer (D): 53,822 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 | EDGAR |
| 2023-03-03 | 4 | Skolnick Phil — Chief Scientific Officer | Disposition to issuer (D): 9,812 @ $20 · Disposition to issuer (D): 11,736 @ $20 · Grant/award (A): 2,000 @ $0 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 40,000 (derivative) @ $0 · Disposition to issuer (D): 13,200 (derivative) @ $0 · +2 more | EDGAR |
| 2023-01-31 | 4 | CRYSTAL ROGER — Chief Executive Officer, Director, 10% owner | Sale (S): 1,358 @ $20.26 | EDGAR |
| 2023-01-31 | 4 | Ellison Mark Jason Heath — Chief Development Officer | Sale (S): 610 @ $20.26 | EDGAR |
| 2023-01-31 | 4 | Gorman Brian | Sale (S): 444 @ $20.26 | EDGAR |
| 2023-01-31 | 4 | O'Toole David D — Chief Financial Officer | Sale (S): 541 @ $20.26 | EDGAR |
| 2023-01-31 | 4 | Skolnick Phil — Chief Scientific Officer | Sale (S): 480 @ $20.26 | EDGAR |
| 2023-01-09 | 4 | O'Toole David D — Chief Financial Officer | Sale (S): 415 @ $20.20 | EDGAR |
| 2023-01-09 | 4 | Ellison Mark Jason Heath — Chief Development Officer | Sale (S): 469 @ $20.20 | EDGAR |
| 2023-01-09 | 4 | CRYSTAL ROGER — Chief Executive Officer, Director, 10% owner | Sale (S): 1,183 @ $20.20 | EDGAR |
| 2023-01-09 | 4 | Skolnick Phil — Chief Scientific Officer | Sale (S): 369 @ $20.20 | EDGAR |
| 2023-01-05 | 4 | Ellison Mark Jason Heath — Chief Development Officer | Sale (S): 1,806 @ $20.20 | EDGAR |
| 2023-01-05 | 4 | O'Toole David D — Chief Financial Officer | Sale (S): 1,600 @ $20.20 | EDGAR |
| 2023-01-05 | 4 | Gorman Brian | Sale (S): 1,313 @ $20.20 | EDGAR |
| 2023-01-05 | 4 | CRYSTAL ROGER — Chief Executive Officer, Director, 10% owner | Sale (S): 5,029 @ $20.20 | EDGAR |
| 2023-01-05 | 4 | Skolnick Phil — Chief Scientific Officer | Sale (S): 1,421 @ $20.20 | EDGAR |
| 2022-07-21 | 4 | Ruth Matthew R. — Chief Commercial Officer | Sale (S): 1,084 @ $10.62 | EDGAR |
| 2022-07-15 | 4 | O'Toole David D — Chief Financial Officer | Sale (S): 779 @ $11.10 | EDGAR |
| 2022-07-15 | 4 | Gorman Brian | Sale (S): 691 @ $11.16 | EDGAR |
| 2022-07-15 | 4 | CRYSTAL ROGER — Chief Executive Officer, Director, 10% owner | Sale (S): 2,246 @ $11.11 | EDGAR |
| 2022-07-15 | 4 | Skolnick Phil — Chief Scientific Officer | Sale (S): 627 @ $11.85 | EDGAR |
| 2022-06-29 | 4 | Ellison Mark Jason Heath — Chief Development Officer | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-29 | 4 | CRYSTAL ROGER — Chief Executive Officer, Director, 10% owner | Grant/award (A): 6,667 @ $0 | EDGAR |
| 2022-06-29 | 4 | O'Toole David D — Chief Financial Officer | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-29 | 4 | Gorman Brian | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-29 | 4 | Ruth Matthew R. — Chief Commercial Officer | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-29 | 4 | Skolnick Phil — Chief Scientific Officer | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-15 | 4 | Sinclair Michael — Director, 10% owner | Sale (S): 5,491 @ $11.09 · Sale (S): 7,225 @ $10.90 · Sale (S): 900 @ $10.60 | EDGAR |
| 2022-06-14 | 4 | Daly Richard J — Director | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-14 | 4 | Lorianne Masuoka K. — Director | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-14 | 4 | MacDougall Ann L. — Director | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-14 | 4 | Silver Gabrielle Alison — Director | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-14 | 4 | Thomas Thomas T. — Director | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-14 | 4 | Collard Craig A — Director | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2022-06-13 | 4 | Sinclair Michael — Director, 10% owner | Sale (S): 7,896 @ $12.25 | EDGAR |
| 2022-06-13 | 4 | Collard Craig A — Director | Purchase (P): 1,663 @ $11.50 · Purchase (P): 4,037 @ $10.94 | EDGAR |
| 2022-06-08 | 4 | Sinclair Michael — Director, 10% owner | Sale (S): 7,688 @ $12.94 · Sale (S): 800 @ $12.86 | EDGAR |
| 2022-06-06 | 4 | Sinclair Michael — Director, 10% owner | Sale (S): 9,736 @ $13.88 · Sale (S): 10,264 @ $13.59 | EDGAR |
| 2022-06-06 | 4 | Gorman Brian | Sale (S): 1,148 @ $13.52 | EDGAR |
Recent 8-K events — OPIANT PHARMACEUTICALS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-03-02 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-01 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-02-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-02-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-01-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2022-11-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-11 | 8-K | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-06-14 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2022-06-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=OPNT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs